𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New prospective in treatment of Parkinson's disease: Studies on permeation of ropinirole through buccal mucosa

✍ Scribed by V. De Caro; G. Giandalia; M.G. Siragusa; F.M. Sutera; L.I. Giannola

Book ID
113655824
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
333 KB
Volume
429
Category
Article
ISSN
0378-5173

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Ropinirole in the treatment of early Par
Ropinirole in the treatment of early Parkinson's disease: A 6-month interim report of a 5-year levodopa-controlled study
✍ Dr. Olivier Rascol; David J. Brooks; Ehrout R. Brunt; Amos D. Korczyn; Warner H. πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 785 KB

The efficacies of ropinirole and levodopa were compared after 6 months of treatment in a planned interim analysis of a 5-year, double-blind, randomized, multicenter study of patients with early Parkinson's disease requiring dopaminergic therapy. The percentage of improvement in the Unified Parkinson

Ropinirole versus bromocriptine in the t
Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6-month interim report of a 3-year study
✍ Prof. Amos D. Korczyn; David J. Brooks; Ehrout R. Brunt; Warner H. Poewe; Olivie πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 705 KB

We compared the efficacy and safety of ropinirole with that of bromocriptine after 6 months of treatment in a planned interim analysis of a 3-year, double-blind, randomized, multicenter study of 335 patients with early Parkinson's disease requiring dopaminergic therapy. Patients, treated with or wit

Prospective comparative study on cost-ef
Prospective comparative study on cost-effectiveness of subthalamic stimulation and best medical treatment in advanced Parkinson's disease
✍ Francesc Valldeoriola; Ossama Morsi; Eduardo Tolosa; Jordi RumiΓ ; Maria JosΓ© Mar πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 152 KB

## Abstract This is an open, prospective, longitudinal study designed to compare two cohorts of patients with advanced Parkinson's disease during 1 year, one undergoing bilateral subthalamic stimulation (STN‐DBS) and the other receiving the best medical treatment (BMT), with respect to the clinical